SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-093200
Filing Date
2024-04-11
Accepted
2024-04-11 16:06:51
Documents
14
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d726485ddef14a.htm DEF 14A 695684
2 GRAPHIC g726485dsp03.jpg GRAPHIC 2233
3 GRAPHIC g726485g0082.jpg GRAPHIC 889
4 GRAPHIC g726485g06a08.jpg GRAPHIC 103732
5 GRAPHIC g726485g08c25.jpg GRAPHIC 110942
6 GRAPHIC g726485g13n02.jpg GRAPHIC 80356
7 GRAPHIC g726485g17p41.jpg GRAPHIC 92933
8 GRAPHIC g726485g45v56.jpg GRAPHIC 103051
9 GRAPHIC g726485g81g00.jpg GRAPHIC 63853
10 GRAPHIC g726485g81g01.jpg GRAPHIC 51846
11 GRAPHIC g726485g81g02.jpg GRAPHIC 4104
12 GRAPHIC g726485g81g03.jpg GRAPHIC 3414
13 GRAPHIC g726485g81g04.jpg GRAPHIC 3478
14 GRAPHIC g726485sp82.jpg GRAPHIC 1039
  Complete submission text file 0001193125-24-093200.txt   1554609
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38692 | Film No.: 24838560
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)